- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07721805
Social Perception of Microtia
The Social Perception of Microtia and Auricular Reconstruction in Children.
Rationale: Microtia is a congenital craniofacial condition characterized by the underdevelopment of the external ear. Children with microtia become aware of their deformity at a young age, and this awareness intensifies in school, where they often face social comparison. This can impact both their mental well-being and social standing. In this process, not only their self-image but also others' perceptions play important roles. Given the significant time children spend with peers, it is crucial to investigate how children of similar ages perceive microtia and whether this perception changes after auricular reconstruction.
Objective: To examine the social perception of children regarding peers with microtia and auricular reconstruction.
Study design: The study is of cross-sectional nature. Study population: The study population consists of primary and secondary school children aged 6 to 18 years old.
Intervention: All children will be shown one of the following photos: a child with a normal ear, a child with preoperative microtia, or a child with a postoperative reconstructed ear. Subsequently, all children will evaluate the photo they have seen using 7 questions based on a visual analogue scale (VAS) ranging from a score of 0 to 10.
Study endpoints: The study includes several endpoints. It will examine children's perception of peers with a normal ear, microtia, or a reconstructed ear in terms of the following social attributes: athleticism, confidence, friendliness, health, intelligence, popularity and willingness to interact. Additionally, it will explore whether there is a difference in the perception of primary school children and secondary school children regarding the above-mentioned social attributes.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Provincie Groningen
-
Groningen, Provincie Groningen, Holland, 9713 GZ
- University Medical Center Groningen
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Attending primary or secondary school
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
Children aged 6-17 years were eligible for participation.
Attending primary or secondary school
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Difference in social perception scores
Tidsramme: The entire assessment can be completed directly after enrollment and takes a maximum of 5 minutes.
|
The primary outcome was the difference in social perception scores between the three image groups.
Responses will be recorded using a visual analogue scale (VAS) ranging from 0 to 100, with higher scores indicating a more favorable perception of the attribute.
|
The entire assessment can be completed directly after enrollment and takes a maximum of 5 minutes.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Differences in social perception scores between primary and secondary school
Tidsramme: The entire assessment can be completed directly after enrollment and takes a maximum of 5 minutes.
|
Secondary analyses examined differences in social perception scores between primary and secondary school students.
Responses will be recorded using a visual analogue scale (VAS) ranging from 0 to 100, with higher scores indicating a more favorable perception of the attribute.
|
The entire assessment can be completed directly after enrollment and takes a maximum of 5 minutes.
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Myrthe KS Hol, Prof. dr., University Medical Center Groningen
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 25059
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mikrotia, medfødt
-
Opus Genetics, IncIkke rekrutterer endnuLeber medfødt amaurose | Leber Congenital Amaurosis (LCA)Forenede Stater
-
Hospital General Dr. Manuel Gea GonzálezUkendtØrebrusk | Blodplader | Microtia-AnotiaMexico
-
Nemours Children's ClinicRekrutteringMikrotia | Ørebrusk | Microtia-Anotia | Mikrotia, medfødt | Øredeformiteter, erhvervet | Øredeformitet eksternt | ØremisdannelseForenede Stater
-
Instituto de Genética OcularAktiv, ikke rekrutterende
-
Cure CMDCongenital Muscle Disease International RegistrTrukket tilbageLAMA2-MD (Merosin Deficient Congenital Muskeldystrofi, MDC1A)Forenede Stater
-
QLT Inc.AfsluttetLCA (Leber Congenital Amaurosis) | RP (Retinitis Pigmentosa)Forenede Stater, Canada, Tyskland, Holland, Det Forenede Kongerige
-
Università Vita-Salute San RaffaeleRekrutteringLAMA2-MD (Merosin Deficient Congenital Muskeldystrofi, MDC1A) | Merosin mangelfuld medfødt muskeldystrofi | Merosin mangelfuld CMD (helt eller delvist) | LAMA2-MD \(Merosin mangelfuld medfødt muskeldystrofi, MDC1A\)Italien
-
MeiraGTx UK II LtdSyne Qua Non LimitedAfsluttetØjensygdomme | Nethindesygdomme | Øjensygdomme, arvelig | Leber Congenital Amaurosis (LCA)Forenede Stater, Det Forenede Kongerige
-
QLT Inc.AfsluttetLeber Congenital Amaurosis (LCA) | Retinitis Pigmentosa (RP)Forenede Stater, Canada, Danmark, Tyskland, Holland, Schweiz, Det Forenede Kongerige
-
QLT Inc.AfsluttetLCA (Leber Congenital Amaurosis) | RP (Retinitis Pigmentosa)Canada, Forenede Stater, Tyskland, Holland, Det Forenede Kongerige